5. It’s Not ‘Just A Uterine Fibroid’ 

In part 1 of 2, Beth Wallace shares her journey leading up to her diagnosis with leiomyosarcoma. 

4. Rapid Hepatitis C Testing Improves Quality of Life Among Young Adults

Same-day results increase the number of individuals who get tested and treated for HCV. 

3. FDA Approves Abemaciclib for Advanced, Metastatic Breast Cancer

Verzenio can be administered as a stand-alone treatment to patients previously treated with endocrine therapy and chemotherapy. 

2. Humira Litigation Comes to a Close, Clearing Path to Biosimilar Launch 

AbbVie grants commercialization rights to Amjevita. 

1. Study: Ending DIR Fees Could Save Medicare Billions

The Improving Transparency and Accuracy in Medicare Part D Spending Act would end direct and indirect remuneration fees. 

News

Breast Cancer

® Breast Cancer Resource Center is a comprehensive resource for clinical news and expert insights on issues related to cancers that occur in the breast, including invasive ductal carcinoma, invasive lobular carcinoma, and less common forms of the disease.

Hepatitis

® Hepatitis Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of a group of distinct diseases that cause inflammation of the liver, including hepatitis A, B, C, and D.

Specialty Pharmacy

® Pharmacy Technician Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to specialty pharmacists.

Oncology

® Oncology Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to oncology pharmacists.

Top news of theÂ weekÂ from Specialty Pharmacy Times.


Ending DIR Fees Could Save Medicare Billions Tops SPT Week in Review